Collectively, our studies demonstrate that the molecular changes endowing an overall immune suppressive and tumor-promoting environment in RDEB occur early in life and are likely imposed by IL-1-initiated cascades that precede TGF-β signaling. The gene discussed is IL1A; the disease is recessive dystrophic epidermolysis bullosa.